178 related articles for article (PubMed ID: 33857776)
1. p16 immunohistochemistry for primary tumor detection in HPV-positive squamous cell carcinoma of unknown primary.
Shan A; Rooper LM; Ryan JF; Eisele DW; Fakhry C
Am J Otolaryngol; 2021; 42(5):103015. PubMed ID: 33857776
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
Wong KS; Krane JF; Jo VY
Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
[TBL] [Abstract][Full Text] [Related]
3. p16 immunostaining in cytology specimens: its application, expression, interpretation, and challenges.
Ribeiro EA; Maleki Z
J Am Soc Cytopathol; 2021; 10(4):414-422. PubMed ID: 33422456
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of p16 expression in FNA specimens from head and neck squamous cell carcinoma and correlation with HPV status.
Abi-Raad R; Prasad ML; Gilani S; Garritano J; Barlow D; Cai G; Adeniran AJ
Cancer Cytopathol; 2021 May; 129(5):394-404. PubMed ID: 33369885
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of high-risk human papillomavirus mRNA in situ hybridisation in squamous cell carcinoma of unknown primary in the head and neck and implementing American Society of Clinical Oncology guideline recommendations.
Daneshpajouhnejad P; Miller JA; Maleki Z
Cytopathology; 2020 Nov; 31(6):547-554. PubMed ID: 32735747
[TBL] [Abstract][Full Text] [Related]
6. ROC analysis of p16 expression in cell blocks of metastatic head and neck squamous cell carcinoma.
Wilson BL; Israel AK; Ettel MG; Lott Limbach AA
J Am Soc Cytopathol; 2021; 10(4):423-428. PubMed ID: 33906829
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients.
Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364
[TBL] [Abstract][Full Text] [Related]
8. Clinical features of human papilloma virus-related head and neck squamous cell carcinoma of an unknown primary site.
Kobayashi K; Saito Y; Omura G; Ando M; Sakamoto T; Yamasoba T; Asakage T
ORL J Otorhinolaryngol Relat Spec; 2014; 76(3):137-46. PubMed ID: 24993345
[TBL] [Abstract][Full Text] [Related]
9. Real-time PCR HPV genotyping in fine needle aspirations of metastatic head and neck squamous cell carcinoma: Exposing the limitations of conventional p16 immunostaining.
El-Salem F; Mansour M; Gitman M; Miles BA; Posner MR; Bakst RL; Genden EM; Westra WH
Oral Oncol; 2019 Mar; 90():74-79. PubMed ID: 30846180
[TBL] [Abstract][Full Text] [Related]
10. Histologic identification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: a reliable predictor of the site of an occult head and neck primary carcinoma.
El-Mofty SK; Zhang MQ; Davila RM
Head Neck Pathol; 2008 Sep; 2(3):163-8. PubMed ID: 20614311
[TBL] [Abstract][Full Text] [Related]
11. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
[TBL] [Abstract][Full Text] [Related]
12. p16 immunostaining in fine-needle aspirations of the head and neck: determining the optimal positivity threshold in HPV-related squamous cell cancer.
Wang Q; Zhou F; Snow JT; Simsir A; Hernandez O; Levine P; Szeto O; Sun W; Givi B; Brandler TC
J Am Soc Cytopathol; 2021; 10(6):592-600. PubMed ID: 34326027
[TBL] [Abstract][Full Text] [Related]
13. Correlation of p16 immunostaining in cell-blocks with corresponding tissue specimens for squamous cell carcinomas of the oropharynx.
Song SJ; Jalaly JB
Cytopathology; 2021 Jan; 32(1):100-107. PubMed ID: 32886831
[TBL] [Abstract][Full Text] [Related]
14. Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status.
Chen ZW; Weinreb I; Kamel-Reid S; Perez-Ordoñez B
Head Neck Pathol; 2012 Dec; 6(4):422-9. PubMed ID: 22801997
[TBL] [Abstract][Full Text] [Related]
15. Double Positivity for HPV DNA/P16
Alsharif U; Hofmann M; Gebhard M; Tharun L; Rades D; Sieg P; Hakim SG
Anticancer Res; 2021 Nov; 41(11):5557-5568. PubMed ID: 34732426
[TBL] [Abstract][Full Text] [Related]
16. Detection of HPV16/18 E6 Oncoproteins in Head and Neck Squamous Cell Carcinoma Using a Protein Immunochromatographic Assay.
Menegaldo A; Schroeder L; Holzinger D; Tirelli G; Dal Cin E; Tofanelli M; Rigo S; Mantovani M; Stellin M; Del Mistro A; Dei Tos AP; Guerriero A; Niero M; Borsetto D; Da Mosto MC; Polesel J; Pawlita M; Waterboer T; Boscolo-Rizzo P
Laryngoscope; 2021 May; 131(5):1042-1048. PubMed ID: 33103777
[TBL] [Abstract][Full Text] [Related]
17. The utility of p16 immunostaining in fine needle aspiration in p16-positive head and neck squamous cell carcinoma.
Xu B; Ghossein R; Lane J; Lin O; Katabi N
Hum Pathol; 2016 Aug; 54():193-200. PubMed ID: 27105759
[TBL] [Abstract][Full Text] [Related]
18. p16 expression in cutaneous squamous carcinomas with neck metastases: a potential pitfall in identifying unknown primaries of the head and neck.
Beadle BM; William WN; McLemore MS; Sturgis EM; Williams MD
Head Neck; 2013 Nov; 35(11):1527-33. PubMed ID: 23108906
[TBL] [Abstract][Full Text] [Related]
19. Utility of p16 and HPV testing in oropharyngeal squamous cell carcinoma: An institutional review.
Abdelhakam DA; Huenerberg KA; Nassar A
Diagn Cytopathol; 2021 Jan; 49(1):54-59. PubMed ID: 32845095
[TBL] [Abstract][Full Text] [Related]
20. The Fidelity of p16 Staining as a Surrogate Marker of Human Papillomavirus Status in Fine-Needle Aspirates and Core Biopsies of Neck Node Metastases: Implications for HPV Testing Protocols.
Holmes BJ; Maleki Z; Westra WH
Acta Cytol; 2015; 59(1):97-103. PubMed ID: 25765380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
